Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM83H Inhibitors

FAM83H inhibitors are a class of chemical compounds that specifically target and inhibit the function of FAM83H, a protein that is part of the FAM83 family. This family of proteins is characterized by the presence of a conserved domain known as the DUF1669 domain, whose functions are still being elucidated. FAM83H is of particular interest because it has been implicated in processes related to the regulation of intracellular signaling pathways, possibly through interactions with other proteins involved in cellular structure and signal transduction. The exact physiological role of FAM83H is not fully understood, but it is known to be involved in cellular differentiation processes, especially in the context of tissues that undergo rapid changes in structure and function, such as dental enamel formation. The inhibition of FAM83H by specific inhibitors typically involves the binding of these molecules to critical regions of the protein, such as the DUF1669 domain or other functional sites that are crucial for its interaction with other cellular proteins. This binding prevents FAM83H from executing its normal role in the cell, which could involve the regulation of cytoskeletal dynamics or influencing the stability and organization of certain cellular components. Inhibiting FAM83H might lead to observable changes in the cellular processes that depend on its activity, such as alterations in cell morphology, disruptions in signal transduction pathways, or impacts on cellular differentiation. By studying the effects of FAM83H inhibition, researchers can gain deeper insights into the specific functions of this protein within the cell, contributing to a broader understanding of the FAM83 family and its role in maintaining cellular structure and function. This understanding is crucial for deciphering the complex network of interactions that govern cellular behavior and the maintenance of tissue integrity.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

5-Fluorouracil, a pyrimidine analog, disrupts RNA and DNA synthesis, potentially influencing FAM83H-related processes in rapidly dividing cells.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporine, an immunosuppressant, can affect signaling pathways and may indirectly modulate FAM83H-related activities.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate, a dihydrofolate reductase inhibitor, interferes with DNA synthesis and cell proliferation, potentially impacting FAM83H functions.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib, a proteasome inhibitor, affects protein degradation pathways, potentially influencing FAM83H-related signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, could indirectly influence FAM83H by altering cellular growth and proliferation pathways.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib, a kinase inhibitor, may have broader effects potentially impacting signaling pathways involving FAM83H.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$75.00
$121.00
33
(1)

Erlotinib, an EGFR inhibitor, might indirectly affect FAM83H activity through EGFR signaling pathways.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib, another EGFR inhibitor, could influence FAM83H indirectly by modulating EGFR-mediated signaling.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib, a BCR-ABL tyrosine kinase inhibitor, may also affect other signaling pathways, potentially influencing FAM83H.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Lapatinib, a dual EGFR and HER2 inhibitor, might impact pathways associated with FAM83H.